Grace Jennings PhD

Grace currently leads the Patient-Centred Outcomes Set development programme at ICHOM. She is currently leading the Kidney Stones, Liver Disease and SMA set development processes, alongside expanding the Set updates, primary subsets and endorsement programmes and leading engagements across the patient, healthcare and life sciences sectors (e.g. the EAST-STROKE trial). Grace has had the opportunity of working with many life sciences stakeholders over the past 13 years. At NICE, she was a Senior Scientific Adviser with NICE Scientific Advice for 7 years, in which time she worked with many pharmaceutical and medtech companies to understand evidence requirements for HTA evaluation, co-developed the Medtech Early Technical Assessment tool (META) and was the technical lead for the new models for evaluating and purchasing antimicrobials project. In the private sector, she was a Director at MAP Patient Access and a Principal at IQVIA, engaging with HQ clients to bring new technologies to marke